Better Buy: Eli Lilly and Co. vs. Merck & Co., Inc.
These big pharma stocks have something for everyone. Income investors love the dividends Eli Lilly and Co. (NYSE: LLY) and Merck & Co., Inc. (NYSE: MRK) pay each quarter, while dreams of successful new drug launches attract growth-minded investors.
Lilly's stock price has risen in line with the broader market this year, but Merck tanked in October. Let's take a closer look at the threats and opportunities facing both to see which of these big pharma stocks is the better pick right now.
Image source: Getty Images.
Source: Fool.com
Eli Lilly Corp. Stock
€741.50
-2.590%
With 62 Buy predictions and 1 Sell predictions Eli Lilly Corp. is one of the favorites of our community.
As a result the target price of 824 € shows a slightly positive potential of 11.13% compared to the current price of 741.5 € for Eli Lilly Corp..
